Global Hepatitis B and C Diagnostics Market 2023-2027

Description

List of Tables

Technavio has been monitoring the hepatitis B and C diagnostics market and is forecast to grow by $2,055.79 mn during 2022-2027, decelerating at a CAGR of 6.12% during the forecast period. Our report on the hepatitis B and C diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for molecular diagnostics in diagnosis of HBV and HCV, strategies of healthcare organizations toward simplifying diagnostic process, and rising demand for POC diagnostics.

Technavio's hepatitis b and c diagnostics market is segmented as below:

By Type

Immunodiagnostics
NAT

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of immunosensors in HBV and HCV diagnostic tests as one of the prime reasons driving the hepatitis B and C diagnostics market growth during the next few years. Also, high demand for biomarker-based tests and increasing awareness and screening program of HBV and HCV diagnostic tests will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hepatitis B and C diagnostics market covers the following areas:

Hepatitis B and C diagnostics market sizing
Hepatitis B and C diagnostics market forecast
Hepatitis B and C diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B and C diagnostics market vendors that include Abbott Laboratories, Bio Rad Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., MedMira Inc., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quidel Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., and Xiamen Innovax Biotech Co. Ltd. Also, the hepatitis B and C diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70927

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global hepatitis B and C diagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global hepatitis B and C diagnostics market 2017 - 2021 ($ million)
4.2 Procedure Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Procedure Segment 2017 - 2021 ($ million)
4.3 Diseases Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Diseases Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Immunodiagnostics - Market size and forecast 2022-2027
Exhibit 34: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
6.4 NAT - Market size and forecast 2022-2027
Exhibit 38: Chart on NAT - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on NAT - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on NAT - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on NAT - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Disease Type

7.1 Market segments
Exhibit 43: Chart on Disease Type - Market share 2022-2027 (%)
Exhibit 44: Data Table on Disease Type - Market share 2022-2027 (%)
7.2 Comparison by Disease Type
Exhibit 45: Chart on Comparison by Disease Type
Exhibit 46: Data Table on Comparison by Disease Type
7.3 Hepatitis B - Market size and forecast 2022-2027
Exhibit 47: Chart on Hepatitis B - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hepatitis B - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hepatitis B - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hepatitis B - Year-over-year growth 2022-2027 (%)
7.4 Hepatitis C - Market size and forecast 2022-2027
Exhibit 51: Chart on Hepatitis C - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Hepatitis C - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Hepatitis C - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Hepatitis C - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Disease Type
Exhibit 55: Market opportunity by Disease Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 104: Abbott Laboratories - Overview
Exhibit 105: Abbott Laboratories - Business segments
Exhibit 106: Abbott Laboratories - Key news
Exhibit 107: Abbott Laboratories - Key offerings
Exhibit 108: Abbott Laboratories - Segment focus
12.4 Bio Rad Laboratories Inc.
Exhibit 109: Bio Rad Laboratories Inc. - Overview
Exhibit 110: Bio Rad Laboratories Inc. - Business segments
Exhibit 111: Bio Rad Laboratories Inc. - Key news
Exhibit 112: Bio Rad Laboratories Inc. - Key offerings
Exhibit 113: Bio Rad Laboratories Inc. - Segment focus
12.5 bioMerieux SA
Exhibit 114: bioMerieux SA - Overview
Exhibit 115: bioMerieux SA - Product / Service
Exhibit 116: bioMerieux SA - Key offerings
12.6 DAAN Gene Co. Ltd.
Exhibit 117: DAAN Gene Co. Ltd. - Overview
Exhibit 118: DAAN Gene Co. Ltd. - Product / Service
Exhibit 119: DAAN Gene Co. Ltd. - Key offerings
12.7 DiaSorin SpA
Exhibit 120: DiaSorin SpA - Overview
Exhibit 121: DiaSorin SpA - Business segments
Exhibit 122: DiaSorin SpA - Key news
Exhibit 123: DiaSorin SpA - Key offerings
Exhibit 124: DiaSorin SpA - Segment focus
12.8 Enzo Biochem Inc.
Exhibit 125: Enzo Biochem Inc. - Overview
Exhibit 126: Enzo Biochem Inc. - Product / Service
Exhibit 127: Enzo Biochem Inc. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Grifols SA
Exhibit 133: Grifols SA - Overview
Exhibit 134: Grifols SA - Business segments
Exhibit 135: Grifols SA - Key offerings
Exhibit 136: Grifols SA - Segment focus
12.11 Hologic Inc.
Exhibit 137: Hologic Inc. - Overview
Exhibit 138: Hologic Inc. - Business segments
Exhibit 139: Hologic Inc. - Key news
Exhibit 140: Hologic Inc. - Key offerings
Exhibit 141: Hologic Inc. - Segment focus
12.12 MedMira Inc.
Exhibit 142: MedMira Inc. - Overview
Exhibit 143: MedMira Inc. - Product / Service
Exhibit 144: MedMira Inc. - Key offerings
12.13 OraSure Technologies Inc.
Exhibit 145: OraSure Technologies Inc. - Overview
Exhibit 146: OraSure Technologies Inc. - Business segments
Exhibit 147: OraSure Technologies Inc. - Key offerings
Exhibit 148: OraSure Technologies Inc. - Segment focus
12.14 PerkinElmer Inc.
Exhibit 149: PerkinElmer Inc. - Overview
Exhibit 150: PerkinElmer Inc. - Business segments
Exhibit 151: PerkinElmer Inc. - Key news
Exhibit 152: PerkinElmer Inc. - Key offerings
Exhibit 153: PerkinElmer Inc. - Segment focus
12.15 QIAGEN NV
Exhibit 154: QIAGEN NV - Overview
Exhibit 155: QIAGEN NV - Product / Service
Exhibit 156: QIAGEN NV - Key news
Exhibit 157: QIAGEN NV - Key offerings
12.16 Randox Laboratories Ltd.
Exhibit 158: Randox Laboratories Ltd. - Overview
Exhibit 159: Randox Laboratories Ltd. - Product / Service
Exhibit 160: Randox Laboratories Ltd. - Key offerings
12.17 Siemens AG
Exhibit 161: Siemens AG - Overview
Exhibit 162: Siemens AG - Business segments
Exhibit 163: Siemens AG - Key news
Exhibit 164: Siemens AG - Key offerings
Exhibit 165: Siemens AG - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations